Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

GWP.L (GWP) Regulatory News

Date Source Headline
18th Feb 2014 10:20 am RNS Blocklisting Interim Review
12th Feb 2014 1:47 pm RNS Additional Listing
10th Feb 2014 5:00 pm RNS Presenting at Leerink Global Healthcare Conference
5th Feb 2014 7:00 am RNS Q1 2014 Financial Results and Operational Progress
31st Jan 2014 3:17 pm RNS Holding(s) in Company
29th Jan 2014 7:00 am RNS Notice of Results
17th Jan 2014 5:11 pm RNS Holding(s) in Company
16th Jan 2014 11:13 am RNS Additional Listing
15th Jan 2014 4:34 pm RNS Holding(s) in Company
15th Jan 2014 4:33 pm RNS Holding(s) in Company
14th Jan 2014 4:23 pm RNS Closing of U.S. Follow-on Offering of Nasdaq ADSs
14th Jan 2014 7:00 am RNS Agreement with Ipsen for Sativex in Latin America
13th Jan 2014 5:00 pm RNS Holding(s) in Company
13th Jan 2014 5:00 pm RNS Holding(s) in Company
9th Jan 2014 7:00 am RNS Raises $87.9m on NASDAQ in U.S. Follow-On Offering
6th Jan 2014 12:18 pm RNS Results of General Meeting
6th Jan 2014 12:13 pm RNS Files Amendment to Registration Statement
20th Dec 2013 2:05 pm RNS Notice of General Meeting and Follow-On Offering
11th Dec 2013 7:00 am RNS U.S. Patent Allowance for Cannabinoids in Glioma
6th Dec 2013 5:52 pm RNS Publication of UK Annual Report and Accounts
2nd Dec 2013 7:00 am RNS Presenting at Piper Jaffray Health Care Conference
29th Nov 2013 2:00 pm RNS Blocklisting Application
27th Nov 2013 7:00 am RNS Sativex Regulatory Approval in Switzerland
26th Nov 2013 5:51 pm RNS Director/PDMR Shareholding
26th Nov 2013 7:00 am RNS Filing of U.S. Annual Report on Form 20-F
19th Nov 2013 7:00 am RNS Final Results
18th Nov 2013 6:00 pm RNS GW Presenting at Jefferies Healthcare Conference
15th Nov 2013 7:00 am RNS Update on Epidiolex in Childhood Epilepsy
12th Nov 2013 7:01 am RNS Notice of Results
11th Nov 2013 7:00 am RNS Phase 1b/2a trial for Glioblastoma Multiforme
21st Oct 2013 7:00 am RNS Successful Closing of Mutual Recognition Procedure
2nd Oct 2013 8:00 am RNS New Sativex Data at ECTRIMS
24th Sep 2013 2:01 pm RNS Grant of Options
23rd Sep 2013 11:41 am RNS Agreement on Sativex Pricing in Germany
20th Sep 2013 7:00 am RNS Presenting at Aegis Capital Healthcare Conference
18th Sep 2013 7:00 am RNS GW Commences Trial of GWP42006 for Epilepsy
19th Aug 2013 7:00 am RNS Blocklisting Interim Review
14th Aug 2013 7:00 am RNS Investigational New Drug Application for Sativex
8th Aug 2013 7:00 am RNS Presenting at the Canaccord Genuity Conference
5th Aug 2013 7:00 am RNS 2013 Third Quarter Financial Results
FTSE 100 Latest
Value8,809.74
Change53.53